The Management of Stable Coronary Artery Disease and Transcatheter Aortic Valve Replacement

Abstract

This review offers a summary of the current evidence on management of patients with combined AS and CAD. We discuss epidemiology, physiology, considerations about why and when CAD should be treated in this patient population, and the natural history of these diseases, all with particular attention to the impact and role of transcatheter aortic valve replacement (TAVR) in the management of AS.